Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 1/20 | 0.46 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 3/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.43 |
| ▸ | PPARA | Q07869 | 2/20 | 0.43 |
| ▸ | CNR1 | P21554 | 2/20 | 0.43 |
| ▸ | CNR2 | P34972 | 2/20 | 0.43 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.43 |
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10794905 | 0.83 | TRPA1 (0.38) | KMT2AGGPS1MEN1CYP3A4MAOB | |
| SCHEMBL9953748 | 0.82 | TRPV1 (0.56) | KMT2APTPN1BACE1GGPS1MEN1 | |
| SCHEMBL31670205 | 0.82 | TRPV1 (0.56) | KMT2APTPN1BACE1GGPS1MEN1 | |
| SCHEMBL793954 | 0.82 | TRPV1 (0.56) | KMT2APTPN1BACE1GGPS1MEN1 | |
| SCHEMBL5823582 | 0.81 | PPARG (0.58) | KMT2APTPN1BACE1GGPS1MEN1 | |
| SCHEMBL17867386 | 0.81 | KMT2A (0.55) | KMT2APTPN1BACE1GGPS1MEN1 | |
| SCHEMBL2072104 | 0.81 | KMT2A (0.52) | KMT2APTPN1BACE1GGPS1MEN1 | |
| SCHEMBL19664772 | 0.81 | PPARG (0.58) | KMT2APTPN1BACE1GGPS1MEN1 | |
| SCHEMBL17867387 | 0.81 | KMT2A (0.55) | KMT2APTPN1BACE1GGPS1MEN1 | |
| SCHEMBL2072101 | 0.81 | KMT2A (0.52) | KMT2APTPN1BACE1GGPS1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2007503516-A | — | — | 2007-02-22 | — | — | JP | claimed |
| EP-1663323-A2 | COMPOSITIONS COMPRISING A DISPERSANT AND MICROCAPSULES CONTAINING AN ACTIVE MATERIAL AND A STABILIZER | THE PROCTER & GAMBLE COMPANY (US) | 2006-06-07 | — | — | EP | claimed |
| US-20050089540-A1 | Compositions comprising a dispersant and microcapsules containing an active material and a stabilizer | THE PROCTER & GAMBLE COMPANY | 2005-04-28 | — | — | US | claimed |
| WO-2005025626-A2 | COMPOSITIONS COMPRISING A DISPERSANT AND MICROCAPSULES CONTAINING AN ACTIVE MATERIAL AND A STABILIZER | THE PROCTER & GAMBLE COMPANY (US) | 2005-03-24 | — | — | WO | claimed |
| EP-3126045-B1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2020-04-29 | — | — | EP | disclosed |
| US-9790253-B2 | OSW-1 analogs and conjugates, and uses thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2017-10-17 | — | — | US | disclosed |
| EP-3126045-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan S.A. (CH) | 2017-02-08 | — | — | EP | disclosed |
| CN-106132531-A | Improvements in or relating to organic compounds | 奇华顿股份有限公司 | 2016-11-16 | — | — | CN | disclosed |
| EP-2926894-A1 | Improvements in or relating to organic compounds | Givaudan SA (CH) | 2015-10-07 | — | — | EP | disclosed |
| CN-103857689-A | OSW-1 analogs and conjugates, and uses thereof | HARVARD COLLEGE | 2014-06-11 | — | — | CN | disclosed |
| US-20140135279-A1 | OSW-1 ANALOGS AND CONJUGATES, AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2014-05-15 | — | — | US | disclosed |
| US-20110319352-A1 | Compounds That Bind Oxysterol Binding Proteins, and Methods of Use Thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2011-12-29 | — | — | US | disclosed |
| WO-2010068877-A2 | COMPOUNDS THAT BIND OXYSTEROL BINDING PROTEINS, AND METHODS OF USE THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-06-17 | — | — | WO | disclosed |
| US-7226607-B2 | Compositions comprising a dispersant and microcapsules containing an active material and a stabilizer | THE PROCTER & GAMBLE COMPANY (US) | 2007-06-05 | — | — | US | disclosed |
| EP-1663323-A2 | COMPOSITIONS COMPRISING A DISPERSANT AND MICROCAPSULES CONTAINING AN ACTIVE MATERIAL AND A STABILIZER | THE PROCTER & GAMBLE COMPANY (US) | 2006-06-07 | — | — | EP | disclosed |
| US-20050089540-A1 | Compositions comprising a dispersant and microcapsules containing an active material and a stabilizer | THE PROCTER & GAMBLE COMPANY | 2005-04-28 | — | — | US | disclosed |
| WO-2005025626-A2 | COMPOSITIONS COMPRISING A DISPERSANT AND MICROCAPSULES CONTAINING AN ACTIVE MATERIAL AND A STABILIZER | THE PROCTER & GAMBLE COMPANY (US) | 2005-03-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319352-A1 | Compounds That Bind Oxysterol Binding Proteins, and Methods of Use Thereof | OSBP, OSBPL3, OSBP2 | KMT2A 4004/4885PTPN1 4464/4885BACE1 214/4885 |
| US-20050089540-A1 | Compositions comprising a dispersant and microcapsules containing an active material and a stabilizer | MLEC, ALB, MSN | KMT2A 4735/4885PTPN1 2237/4885BACE1 3379/4885 |
| US-20140135279-A1 | OSW-1 ANALOGS AND CONJUGATES, AND USES THEREOF | OSBP, OSBP2, OSBPL3 | KMT2A 3951/4885PTPN1 2026/4885BACE1 859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.